CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 134 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $0 | – | 900 | 0.0% | 0.00% | – |
Q3 2018 | $0 | – | 900 | 0.0% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 900 | -52.6% | 0.00% | – |
Q1 2018 | $5,000 | 0.0% | 1,900 | 0.0% | 0.00% | – |
Q4 2017 | $5,000 | -64.3% | 1,900 | -60.5% | 0.00% | -100.0% |
Q3 2017 | $14,000 | +16.7% | 4,815 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $12,000 | -29.4% | 4,815 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $17,000 | +21.4% | 4,815 | +18.0% | 0.00% | 0.0% |
Q4 2016 | $14,000 | -12.5% | 4,081 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $16,000 | -11.1% | 4,081 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $18,000 | +80.0% | 4,081 | +551.9% | 0.00% | 0.0% |
Q4 2015 | $10,000 | – | 626 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $19,497,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $17,928,000 | 2.31% |
TSP Capital Management Group, LLC | 1,278,057 | $3,630,000 | 1.65% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 10,772,111 | $30,593,000 | 0.46% |
Virtus ETF Advisers LLC | 118,969 | $338,000 | 0.42% |
Benchmark Capital Advisors | 61,000 | $173,000 | 0.14% |
ASCEND CAPITAL, LLC | 873,995 | $2,482,000 | 0.09% |
SHEPHERD KAPLAN KROCHUK, LLC | 44,521 | $126,000 | 0.08% |
Vident Investment Advisory, LLC | 427,578 | $1,214,000 | 0.06% |
NJ State Employees Deferred Compensation Plan | 80,000 | $227,000 | 0.04% |